PMS-Pazopanib 200 mg tablet; Presence of Sorafenib
· Published by Health Canada · Official notice
Alert type: Health product recall
Category: Health products - Drugs
Product: PMS-Pazopanib 200 mg tablet
Issue: Health products - Product quality
What to do: Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Audience: General public, Healthcare, Industry
Recall class: Type II
| Brand | Product Name | Market Authorization | Dosage Form | Lot number | Strength |
|---|
| Pharmascience | PMS-Pazopanib 200 mg tablet | DIN 02525666 | Tablet | E0201K, E0201J | Pazopanib hydrochloride 200 mg |
Presence of Sorafenib in affected lots.